Drug costs in context: assessing drug costs in cost-of-illness analyses [PDF]
Drugs in Context, 2022 Cost-of-illness (COI) studies attempt to measure and describe the costs associated or attributed to a specific disease, but there are several considerations for measuring and interpreting drug costs estimates.
T Joseph Mattingly II, Shannon Weathers
doaj +4 more sources
The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis [PDF]
Frontiers in Public Health, 2023 BackgroundIn April 2009, the Chinese government launched Zero Markup Drug Policy (ZMDP) to adjust medical institutions' revenue and expenditure structures.ObjectiveThis study evaluated the impact of implementing ZMDP (as an intervention) on the drug ...
Ruilin Wang +12 more
doaj +2 more sources
What will it take for an injectable ARV to change the face of the HIV epidemic in high-prevalence countries? Considerations regarding drug costs and operations. [PDF]
J Int AIDS Soc, 2023 Meyer-Rath G, Jamieson L, Pillay Y.
europepmc +3 more sources
The misrepresentation of high drug costs: Who is looking out for the patient? [PDF]
Can Pharm J (Ott), 2017 Bachynsky JA, Tsuyuki RT.
europepmc +3 more sources
The challenges of access to innovative medicines with limited evidence in the European Union
Frontiers in Pharmacology, 2023 The European Medicines Agency (EMA) fosters access to innovative medicines through accelerated procedures and flexibility in the authorization requirements for diseases with unmet medical needs, such as many rare diseases as well as oncological diseases.
Antonio Vallano +7 more
doaj +1 more source
Pharmaceuticals, 2021 This study aimed to compare drug costs and healthcare costs of a 1 year adjuvant course with intravenous biosimilar trastuzumab vs. subcutaneous reference trastuzumab in HER2-positive breast cancer from the Belgian hospital perspective. Our simulation is
Steven Simoens +2 more
doaj +1 more source
Pharmaceutics, 2021 High medication costs are one of the major barriers to patient adherence. Medication affordability might be improved by generic substitution. The aim of this study was to assess the effectiveness of the implementation of generic substitution mechanisms ...
Przemysław Kardas +7 more
doaj +1 more source
Functional Limitations, Medication Support, and Responses to Drug Costs among Medicare Beneficiaries. [PDF]
PLoS One, 2015 Whaley C, Reed M, Hsu J, Fung V.
europepmc +3 more sources
Treatment Access, Health Economics, and the Wave of a Magic Wand
Current Oncology, 2022 New drugs are expensive, in part due to excessive drug development costs. Governments are trying to reduce drug prices. This can delay access to effective agents. A country’s access to new drugs correlates with prices they agree to pay.
David J. Stewart +2 more
doaj +1 more source